The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.38
Bid: 0.00
Ask: 1.39
Change: 0.00 (0.00%)
Spread: 0.03 (2.206%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.38
RTW Live PriceLast checked at -
RTW Venture is an Investment Trust

To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

16 Feb 2024 16:50

RNS Number : 5050D
RTW Biotech Opportunities Ltd
16 February 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GG00BKTRRM22

Issuer Name

RTW BIOTECH OPPORTUNITIES LTD

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

Other

Comments

As a result of the recent issuance of new ordinary shares of RTW Biotech Opportunities Ltd ("RTW"), Bluestem's interest in RTW has been diluted to 8.74% which then triggers the notification threshold.

3. Details of person subject to the notification obligation

Name

Bluestem Asset Management, LLC

City of registered office (if applicable)

Charlottesville

Country of registered office (if applicable)

United States

Name

City of registered office

Country of registered office

Bluestem Partners, LP

Wilmington Delaware

USA

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

13-Feb-2024

6. Date on which Issuer notified

16-Feb-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

8.740000

0.000000

8.740000

34093156

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GG00BKTRRM22

34093156

0

8.740000

0.000000

Sub Total 8.A

34093156

8.740000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Michael D. Bills

Bluestem Asset Management LLC

8.740000

0.000000

8.740000%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

Michael D. Bills has sole authority for Bluestem Asset Management, LLC, as its Managing Member. Bluestem Asset Management, LLC is the General Partner of the Shareholder, Bluestem Partners, LP, and is authorized to act for Bluestem Partners, LP on all matters.The last notification was submitted to the FCA and the issuer on 9/28/2020 via email. Bluestem's interest in RTW Venture Fund Limited (as RTW Biotech Opportunities Ltd was formerly known) held thru Vidacos Nominees Limited was 34,093,156 shares or around 18.96%.

12. Date of Completion

16/02/2024

13. Place Of Completion

Charlottesville, VA USA

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLDZGMZVVRGDZM
Date   Source Headline
31st Mar 20227:00 amRNSAnnual Financial Report
14th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSNotice of Annual Report
17th Feb 20227:50 amRNSAdditional Investment in Magnolia Medical
16th Feb 202212:45 pmRNSNew Investment in Third Harmonic Bio
14th Feb 20227:00 amRNSNet Asset Value(s)
26th Jan 20222:00 pmRNSNew Investment in Kyverna
24th Jan 20227:00 amRNSQuarterly Update
14th Jan 20227:00 amRNSNet Asset Value(s)
12th Jan 20228:05 amEQSEdison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment
10th Jan 20227:00 amRNSPortfolio Company Update: CinCor Pharma IPO
14th Dec 20217:00 amRNSNet Asset Value(s)
12th Nov 20217:00 amRNSNet Asset Value(s)
26th Oct 20217:00 amRNSQuarterly Update
22nd Oct 20217:00 amRNSPortfolio Company Update: Ventyx IPO
14th Oct 20217:00 amRNSNet Asset Value(s)
13th Oct 20217:00 amRNSNew Investment in CinCor Pharma
11th Oct 20217:00 amRNSPortfolio Company Update: Pyxis IPO
1st Oct 20217:00 amRNSTotal Voting Rights
21st Sep 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20217:00 amRNSIssue of Equity
16th Sep 20215:48 pmRNSAnnouncement of Share Issuance
16th Sep 20217:00 amRNSHalf-year Report
15th Sep 20217:00 amRNSNet Asset Value(s)
9th Sep 202112:00 pmRNSNew Investment in Lycia
9th Sep 20217:00 amRNSNew Investment in InBrace
1st Sep 20217:00 amRNSTotal Voting Rights
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSNotice of Interim Report
17th Aug 20217:00 amRNSIssue of Equity
13th Aug 20214:05 pmRNSAnnouncement of Share Issuance
13th Aug 20217:00 amRNSNet Asset Value(s)
6th Aug 20217:00 amRNSCompletion of Transfer
5th Aug 20211:00 pmRNSTransfer to the Premium Segment of the LSE
2nd Aug 20217:01 amRNSPortfolio Company Update: Tenaya Therapeutics IPO
2nd Aug 20217:00 amRNSQuarterly Update
30th Jul 20213:50 pmRNSResult of Meeting
27th Jul 20217:05 amRNSNew Investment in Artios
15th Jul 20217:00 amRNSNet Asset Value(s)
14th Jul 20217:05 amRNSPortfolio Company Update
14th Jul 20217:00 amRNSPublication of Circular
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:00 amRNSPortfolio Company Update: GH Research IPO
25th Jun 20217:00 amRNSPortfolio Company Update: Monte Rosa IPO
22nd Jun 20214:49 pmRNSResult of AGM
18th Jun 20214:40 pmRNSSecond Price Monitoring Extn
18th Jun 20214:35 pmRNSPrice Monitoring Extension
16th Jun 20217:00 amRNSIssue of Equity
15th Jun 202112:05 pmRNSNew Investment in Umoja Biopharma

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.